Krystal Biotech, Inc. (NASDAQ:KRYS) Given Average Rating of "Buy" by Analysts
Krystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) has been given an average recommendation of "Buy" by the eleven analysts that are currently covering the stock, MarketBeat.com reports. One...